Related Experiment Video
Updated: Aug 19, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 3, 2013
The identification and screening of men at high risk for developing prostate cancer
1Englewood-Mount Sinai Cancer Risk Assessment and Counselling Program, Mount Sinai School of Medicine/Englewood Hospital and Medical Center, Englewood, NJ, USA.
Abstract:
It is estimated that the lifetime risk of being diagnosed with prostate cancer is 1 in 5. The identification of risk factors, including age, African-American ancestry, family history, and possibly diet and environmental factors, has allowed health care professionals the opportunity to identify, screen, and study men at the greatest risk of developing prostate cancer. The risk factors, current screening tools, and the informed consent process for men participating in a prostate cancer screening program are outlined.

